|
Delayed
London S.E.
|
5-day change | 1st Jan Change | ||
| - GBX | -.--% |
|
-0.31% | +19.70% |
| 08-11 | Cello Health Limited Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-04 | Cello Health Limited Reports Earnings Results for the Full Year Ended December 31, 2024 | CI |
| Market Cap | 179M 237M 210M 196M 337M 22.75B 340M 2.37B 920M 11.63B 888M 869M 37.32B | P/E 2024 |
43.4x | P/E 2025 | -109x |
|---|---|---|---|---|---|
| Enterprise Value | 179M 237M 210M 196M 337M 22.75B 341M 2.38B 920M 11.63B 889M 869M 37.33B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 | - |
| 11/08/20 | Killik & Co. LLP : - Form 8.3 - Cello Health Plc | PR |
| 28/07/20 | Cello Health : Form 8.3 - - (HHL) | AQ |
| 10/07/20 | Premier Miton Group Plc : - Form 8.3 - Cello Health Plc | PR |
| 08/07/20 | Premier Miton Group Plc : - Form 8.3 - Cello Health Plc | PR |
| 07/07/20 | Killik & Co. LLP : - Form 8.3 - Cello Health Plc | PR |
| Manager | Title | Age | Since |
|---|---|---|---|
Rebecca Hyde
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jon Williams
BRD | Director/Board Member | 51 | 13/08/2020 |
Michael Madden
BRD | Director/Board Member | 47 | 15/12/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/30/20 A | Free | 80,000 | 0.0752% | |||
| 3/30/20 A | Free | Chief Operating Officer | 265,000 | 0.2492% | ||
| 3/30/20 A | Free | Chief Financial Officer | 250,000 | 0.2351% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | 4.12M 5.46M 4.85M 4.53M 7.78M 525M 7.85M 54.77M 21.22M 268M 20.49M 20.05M 861M | -1.64M -2.16M -1.92M -1.79M -3.09M -208M -3.11M -21.72M -8.42M -106M -8.13M -7.95M -341M |
| Net Debt | 1.34M 1.77M 1.58M 1.47M 2.53M 171M 2.55M 17.8M 6.9M 87.19M 6.66M 6.52M 280M | 42K 55.57K 49.37K 46.08K 79.21K 5.34M 79.95K 558K 216K 2.73M 209K 204K 8.76M |
Employees
-
Sector
-
- Stock Market
- Stocks
- CLL Stock
Select your edition
All financial news and data tailored to specific country editions
